Navigation Links
EntreMed to Present at The New York Society of Security Analysts Industry Conference
Date:12/5/2007

ROCKVILLE, Md., Dec. 5 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S. Burns, President and Chief Executive Officer, will present a Company overview at the NYSSA 2007 Biotech and Specialty Pharmaceuticals Industry Conference, to be held at the Conference Facilities at the NYSSA, New York, December 11-12, 2007. Mr. Burns' presentation is scheduled for Tuesday, December 11, 2007, at 1:35 p.m. (local time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Mr. Burns' live presentation will be web cast and can be accessed through the Company's web site at http://www.entremed.com. An archive will be available on the web site for approximately 90 days.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. Panzem(R) NCD (2-methoxyestradiol or 2ME2) is currently in multiple Phase 2 clinical trials for cancer. MKC-1, an oral cell-cycle regulator, is in multiple Phase 1 and 2 studies for cancer. ENMD-1198, a novel tubulin-binding agent, is in Phase 1 studies in advanced cancers. Panzem(R) is also in preclinical development for rheumatoid arthritis, and ENMD-2076, a dual-acting Aurora-angiogenesis inhibitor, is in preclinical development for cancer. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammatio
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 22, 2014 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of ... clinical results from its Phase IIa clinical trial ... to treat type 1 diabetes. The trial was conducted ... under a U.S. Food and Drug Administration (FDA) ...
(Date:10/22/2014)... CITY, Calif., Oct. 21, 2014 Abaxis, Inc. ... manufacturing point-of-care blood analysis systems, today reported financial results ... Second quarter overview: , Revenues of ... , Diluted EPS of $0.24, up 33% over ... , Service revenues from Abaxis Veterinary Reference Laboratories (AVRL) ...
(Date:10/22/2014)... -- InVivo Therapeutics Holdings Corp. (OTCQB: NVIV) based in ... cord injury (SCI) treatment with their novel Neuro-Spinal Scaffold. ... regrowth in the spinal cord area when cells are ... polymer, the scaffold ultimately breaks down to water and ... NVIV has recently attracted significant investor attention with the ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3
... BETHESDA, Md., Sept. 6, 2011 Spherix Incorporated (NASDAQ: ... for therapy in diabetes, metabolic syndrome and atherosclerosis, and ... supplement, biotechnology and pharmaceutical companies -- today announced that ... Lodder, President, will be presenting a corporate overview at ...
... Sept. 6, 2011 ActiveCare, Inc. (ACAR.OB) a leader ... for the strategic partnership with Mountain Home Medical, Inc. ... products in Colorado.   Working with county and state ... being monitored by ActiveCare.  "We have been working closely ...
Cached Medicine Technology:Spherix Incorporated to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 2ActiveCare, Inc. Announces Government Reimbursement for Product and Services 2
(Date:10/25/2014)... News) -- October,s shorter, darker days can trigger a ... to an expert. People affected by seasonal ... lack motivation and even have trouble getting out of ... said Dr. Angelos Halaris, a professor in the department ... Stitch School of Medicine. "Seasonal affective disorder should ...
(Date:10/22/2014)... Medical Solutions , the nation’s ... announce that our co-founder and CFO, Scott Anderson, ... 100 for 2014. Anderson was also named to ... in the staffing industry,” in 2013.     , Under ... staffing company in the U.S., was named a ...
(Date:10/22/2014)... 21, 2014 (HealthDay News) -- The United States ... from Ebola-affected nations of West Africa land at ... for infection with the virus. In a ... noted that 94 percent of air passengers from ... one of these five airports -- New York ...
(Date:10/22/2014)... 22, 2014 With the Affordable Care Act ... by the American Institutes for Research (AIR) finds that three ... use health insurance, but 42 percent say they are not ... before signing up for coverage. , The AIR survey found ... percent able to calculate correctly how much they owe for ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Losing Weight Your ... industry is staring you in the face, it certainly can ... not do your body an extra favor by doing it ... tempting crash diets. Instead, listen to your body, exercise regularly, ... Exercise is essential to losing weight; you need to exercise ...
Breaking Medicine News(10 mins):Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:Medical Solutions Co-Founder/CFO Scott Anderson Named to Staffing Industry Analysts’ 2014 Staffing 100 2Health News:Medical Solutions Co-Founder/CFO Scott Anderson Named to Staffing Industry Analysts’ 2014 Staffing 100 3Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2
... in Washington D.C. , ... Los Angeles , Calif. and ... Growth and Revitalization , WASHINGTON, Nov. 23 DaVita, the nation,s ... designed to create jobs and spur revitalization in minority communities across the ...
... , TUCSON, Ariz., Nov. 23 Cortiva ... on Sunday, Dec. 6 from 1-3 p.m. at the school,s ... for participants to learn and practice basic massage strokes. ... Tucson is growing right along with it," said Joann McMaster, ...
... can impair breathing, protein may be the cause , MONDAY, ... identified a protein that causes nasal and sinus polyps ... chronic sinusitis. , The condition is one of the most ... the nasal passages. Polyps - unhealthy overgrowths of sinus tissue ...
... get far more screen time than those in ... News) --Young children of working parents may watch even ... especially kids in home-based day-care settings, a new study ... University of Washington surveyed day-care directors to find out ...
... , ... Reportlinker.com announces that a new market research ... http://www.reportlinker.com/p0165298/Childrens-Food-and-Drinks-in-Europe---A-Guide-to-Markets-Products-and-Innovation-2nd-Edition.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , Despite ... world,s ageing population, children remain a significant ...
... between mental and physical health , MONDAY, Nov. 23 (HealthDay ... your life as smoking does, a new study suggests. , ... better for longevity than just depression. , Researchers came to ... more than 60,000 people. During the four years after the ...
Cached Medicine News:Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 2Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 4Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 5Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 6Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 7Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 8Health News:Depression May Up Death Risk to That of Smoking 2
...
EDM Ventricular Drainage Kit, with Drip Chamber with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in ...
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
... The CODMAN EDS 3 CSF External Drainage System ... nurses and physicians. The clinicians who work every ... the CODMAN EDS 3: ease-of-use in an integrated ... valve, accurate hydrostatic leveling from a unique ...
Medicine Products: